𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases

✍ Scribed by Hidekazu Kuramochi; Kazuhiko Hayashi; Go Nakajima; Hirotaka Kamikozuru; Masakazu Yamamoto; Kathleen D. Danenberg; Peter V. Danenberg


Publisher
Springer
Year
2009
Tongue
English
Weight
303 KB
Volume
65
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Clinical relevance of transforming growt
✍ Koert P. De Jong; Rudi Stellema; Arend Karrenbeld; Jan Koudstaal; Annette S. Gou πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 513 KB

To determine whether the expression of transforming growth factor alpha (TGF-alpha), its receptor (epidermal growth factor receptor [EGFr]), p53 nuclear protein, and proliferation influences prognosis of patients with liver metastases, a study was performed in 45 liver metastases and 33 correspondin

5-fluorouracil-related gene expression l
✍ Hidekazu Kuramochi; Kazuhiko Hayashi; Kazumi Uchida; Satoru Miyakura; Daisuke Sh πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 103 KB πŸ‘ 1 views

## Abstract Gene expression levels of thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), thymidine phosphorylase (TP) and orotate phosphoribosyl transferase (OPRT) have been shown to be associated with response to 5‐fluorouracil‐based therapies. Analyzing these gene expression levels

Inhibition of proliferation and inductio
✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 297 KB πŸ‘ 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant

Bombesin/gastrin-releasing peptide antag
✍ MiklΓ³s KoppΓ‘n; GΓ‘bor Halmos; JosΓ© M. Arencibia; Najib Lamharzi; Andrew V. Schall πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 134 KB πŸ‘ 1 views

## BACKGROUND. Antagonists of bombesin/gastrin-releasing peptide (BN/GRP) have been developed to block the autocrine stimulatory effect of BN/GRP on tumors such as small cell lung carcinoma (SCLC). Although several studies have addressed the intracellular events that follow the formation of the re